Graves' Disease: Understanding the Most Common Cause of Hyperthyroidism

What Is Graves’ Disease?

Graves’ disease is an autoimmune disorder that causes the thyroid gland to produce excessive thyroid hormones (hyperthyroidism). It is the most common cause of hyperthyroidism, accounting for 60–80% of all cases.

Named after Irish physician Robert Graves, this condition occurs when the immune system produces antibodies called Thyroid Stimulating Immunoglobulins (TSI) that mimic TSH and continuously stimulate the thyroid gland to overproduce hormones.

It affects women 5–10 times more frequently than men and most commonly occurs between ages 30–50.

What Causes Graves’ Disease?

Like other autoimmune conditions, Graves’ disease results from a combination of factors:

• Genetic predisposition — family history of thyroid or autoimmune diseases
• Environmental triggers — stress, infections, smoking, iodine excess
• Hormonal factors — more common in women, often triggered during post-partum period
• Other autoimmune conditions — higher risk if you have Type 1 diabetes, rheumatoid arthritis, celiac disease, or vitiligo

Smoking is a particularly strong risk factor, especially for developing thyroid eye disease.

Symptoms of Graves’ Disease

Excess thyroid hormones accelerate the body’s metabolism, causing:

General Symptoms

• Unintentional weight loss despite increased appetite
• Heat intolerance — feeling hot when others are comfortable
• Excessive sweating
• Rapid or irregular heartbeat (palpitations, atrial fibrillation)
• Tremor — fine shaking of hands and fingers
• Anxiety, irritability, nervousness
• Difficulty sleeping (insomnia)
• Fatigue and muscle weakness
• Frequent bowel movements or diarrhea
• Light or absent menstrual periods

Thyroid-Specific Signs

• Diffuse goiter — enlarged thyroid gland, smooth and non-tender
• Thyroid bruit — audible blood flow sound over the thyroid (due to increased blood flow)

Graves’ Ophthalmopathy (Thyroid Eye Disease)

Affecting 25–50% of patients, this is a hallmark feature:

• Bulging eyes (proptosis/exophthalmos)
• Eye redness and irritation
• Excessive tearing
• Gritty or sandy feeling in the eyes
• Swelling around the eyes
• Double vision (diplopia)
• Light sensitivity
• In severe cases — vision loss due to optic nerve compression

Important: Thyroid eye disease can occur before, during, or after the onset of hyperthyroidism, and can worsen even after thyroid hormone levels are controlled.

Graves’ Dermopathy (Rare)

• Pretibial myxedema — thickened, reddish, lumpy skin on the shins
• Occurs in only 1–5% of patients

How Is Graves’ Disease Diagnosed?

Blood Tests

Test	Expected Finding
TSH	Suppressed (very low, often < 0.01)
Free T4	Elevated
Free T3	Elevated (sometimes T3 rises before T4)
TSH Receptor Antibodies (TRAb/TSI)	Positive — confirms Graves’ disease
Anti-TPO antibodies	Often positive

Additional Investigations

• Thyroid uptake scan (Tc-99m/I-131) — shows diffusely increased uptake (distinguishes from thyroiditis)
• Thyroid ultrasound — enlarged gland with increased blood flow (thyroid inferno pattern)
• Eye assessment — clinical evaluation, CT/MRI orbit if eye disease is suspected

Treatment Options

There are three main treatment approaches. The choice depends on age, severity, pregnancy plans, eye disease, and patient preference.

1. Anti-Thyroid Medications (ATDs)

First-line treatment in most cases, especially in India:

• Carbimazole/Methimazole — preferred drug

  • Blocks thyroid hormone production
  • Started at higher doses, then gradually reduced (titration or block-replace regimen)
  • Treatment duration: 12–18 months typically
  • Remission rate: 40–60% after a full course

• Propylthiouracil (PTU) — used in first trimester of pregnancy and thyroid storm

Monitoring during ATD therapy:

• Regular thyroid function tests (every 4–6 weeks initially)
• Watch for side effects:
  • Skin rash (common, usually mild)
  • Liver enzyme elevation
  • Agranulocytosis (rare but serious) — report sore throat or fever immediately

Beta-blockers (Propranolol) — used alongside ATDs to control symptoms (palpitations, tremor, anxiety) until thyroid hormones normalize.

2. Radioactive Iodine (RAI) Therapy

• Involves swallowing a capsule of Iodine-131
• The radioactive iodine is taken up by the overactive thyroid and destroys thyroid cells
• Usually results in hypothyroidism within 2–6 months (requires lifelong levothyroxine)
• Not suitable during pregnancy or breastfeeding
• May worsen thyroid eye disease — requires corticosteroid cover in patients with eye involvement
• Commonly used after ATD failure or relapse

3. Surgery (Thyroidectomy)

• Total or near-total thyroidectomy
• Indicated when:
  • Large goiter causing compression symptoms
  • Suspicious thyroid nodules co-exist
  • ATDs not tolerated and RAI contraindicated
  • Patient preference for definitive treatment
  • Severe Graves’ eye disease (surgery preferred over RAI)
• Results in hypothyroidism — requires lifelong levothyroxine
• Risks: damage to parathyroid glands (hypoparathyroidism) and recurrent laryngeal nerve (voice changes) — both uncommon in experienced hands

Managing Graves’ Eye Disease

Thyroid eye disease requires special attention:

• Quit smoking — the single most important modifiable factor
• Selenium supplementation — 200 mcg/day for 6 months (shown to improve mild eye disease)
• Artificial tears and eye lubricants — for dryness and irritation
• Prisms or corrective lenses — for double vision
• Systemic corticosteroids — for moderate-to-severe active eye disease
• Orbital radiotherapy or Teprotumumab — for refractory cases
• Surgical decompression — for sight-threatening disease
• Maintain euthyroidism — both hyper and hypothyroidism worsen eye disease

Graves’ Disease and Pregnancy

Graves’ disease requires careful management during pregnancy:

• Pre-conception planning is ideal — achieve remission or stable control before conceiving
• PTU preferred in first trimester (methimazole has a small risk of birth defects)
• Methimazole can be used from second trimester onward
• Lowest effective dose should be used
• TRAb levels in third trimester — to assess risk of neonatal thyrotoxicosis
• Regular monitoring by both endocrinologist and obstetrician

What Happens After Remission?

After completing a course of anti-thyroid medications:

• 40–60% achieve remission (normal thyroid function without medication)
• Relapse occurs in 40–60%, usually within the first 2 years
• Risk factors for relapse: large goiter, high TRAb levels, severe hyperthyroidism at diagnosis, smoking
• Lifelong monitoring is recommended — annual thyroid function tests even after remission

The Bottom Line

Graves’ disease is a treatable autoimmune condition. With proper diagnosis, appropriate treatment selection, and regular follow-up, most patients achieve excellent outcomes. The key is individualized treatment — there is no one-size-fits-all approach.

“Graves’ disease requires careful, individualized management — especially when the eyes are involved. An experienced endocrinologist can guide you through the best treatment path.”

If you have symptoms of an overactive thyroid or have been diagnosed with Graves’ disease, consult an endocrinologist for comprehensive evaluation and treatment planning.